ProQR Therapeutics (PRQR)
(Delayed Data from NSDQ)
$2.90 USD
-0.25 (-7.94%)
Updated Feb 6, 2023 04:00 PM ET
Pre-Market: $2.90 0.00 (0.00%) 9:12 AM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/23/2023
Time: -- |
12/2022 | $-0.20 | 0.00% |
Earnings Summary
For their last quarter, ProQR Therapeutics (PRQR) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.23 per share. This reflects a negative earnings surprise of 47.83%. Look out for PRQR's next earnings release expected on February 23, 2023. For the next earning release, we expect the company to report earnings of -$0.20 per share, reflecting a year-over-year increase of 33.33%.
Earnings History
Price & Consensus
Zacks News for PRQR
ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly
PRQR: What are Zacks experts saying now?
Zacks Private Portfolio Services